Evidence map›Paper›PMID 22362424›Full record

ReviewNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2012

Genetic manipulation of cell death and neuroplasticity pathways in traumatic brain injury.

Kathleen M Schoch, Sindhu K Madathil, Kathryn E Saatman

Open access · bronzeAbstract readReview
In one paragraph

Review in Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Mechanosensation in traumatic brain injury.Neurobiology of disease · 2021
    Review
  9. Article
  10. Role of Pyroptosis in Traumatic Brain and Spinal Cord Injuries.International journal of biological sciences · 2020
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Kathleen M SchochSpinal Cord and Brain Injury Research Center and Department of Physiology, University of Kentucky College of Medicine, B473 Biomedical and Biological Sciences Research Building-BBSRB, 741 South Limestone Street, Lexington, KY 40536, USA.
Sindhu K Madathil
Kathryn E Saatman
University of Kentucky · US

Funding

Role of calpastatin in modulating function following TBIP01NS058484 · NINDS · UNIVERSITY OF KENTUCKY · PI GUTTMANN, RODNEY P · 2007 to 2011
$4.8M
Preclinical evaluation of IGF1 therapy for traumatic brain injuryR01NS072302 · NINDS · UNIVERSITY OF KENTUCKY · PI SAATMAN, KATHRYN E · 2011 to 2015
$1.8M
Calpastatin overexpression as a therapeutic approach to traumatic brain injuryF31NS071804 · NINDS · UNIVERSITY OF KENTUCKY · PI SCHOCH, KATHLEEN MARIE · 2011 to 2013
$71k
NINDS NIH HHS F31 NS071804NINDS NIH HHS NS058484NINDS NIH HHS NS071804NINDS NIH HHS NS072302NINDS NIH HHS P01 NS058484NINDS NIH HHS R01 NS072302
6 · The paper itself

Abstract

Traumatic brain injury (TBI) initiates a complex cascade of secondary neurodegenerative mechanisms contributing to cell dysfunction and necrotic and apoptotic cell death. The injured brain responds by activating endogenous reparative processes to counter the neurodegeneration or remodel the brain to enhance functional recovery. A vast array of genetically altered mice provide a unique opportunity to target single genes or proteins to better understand their role in cell death and endogenous repair after TBI. Among the earliest targets for transgenic and knockout studies in TBI have been programmed cell death mediators, such as the Bcl-2 family of proteins, caspases, and caspase-independent pathways. In addition, the role of cell cycle regulatory elements in the posttraumatic cell death pathway has been explored in mouse models. As interest grows in neuroplasticity in TBI, the use of transgenic and knockout mice in studies focused on gliogenesis, neurogenesis, and the balance of growth-promoting and growth-inhibiting molecules has increased in recent years. With proper consideration of potential effects of constitutive gene alteration, traditional transgenic and knockout models can provide valuable insights into TBI pathobiology. Through increasing sophistication of conditional and cell-type specific genetic manipulations, TBI studies in genetically altered mice will be increasingly useful for identification and validation of novel therapeutic targets.

Indexed as

Genetic TechniquesAnimalsAnimals, Genetically ModifiedBrain InjuriesCell DeathGene Knockdown TechniquesHumansNeuronal PlasticitySignal Transduction

Identifiers

PMID22362424
PMCPMC3337028
OpenAlexW2086656347

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.